Gingiva Mesenchymal Stem Cells Treatment of Chronic Periodontitis

NCT03137979 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-05-03

No results posted yet for this study

Summary

This study is to evaluate the safety and efficacy of Gingiva Mesenchymal Stem Cell Therapy for Chronic Adult Periodontitis.

Conditions

  • Periodontitis

Interventions

BIOLOGICAL

GMSCs and collagen scaffolds

Patients in this group were given GMSCs and collagen scaffolds.

BIOLOGICAL

Collagen scaffolds

Patients in this group were given collagen scaffolds.

PROCEDURE

Open flap debridement

The patients in this group will only receive the treatment of open flap debridement.

Sponsors & Collaborators

  • Hebei Medical University

    lead OTHER

Principal Investigators

  • Baoyong Yan, Doctor · Hebei Medical University

  • Guangshun Liu, Master · The First Hospital of Hebei Medical University

  • Quanhai Li, Doctor · The First Hospital of Hebei Medical University

  • Xianyun Wang, Doctor · The First Hospital of Hebei Medical University

  • Jinhong Zhang, Master · The First Hospital of Hebei Medical University

  • Yao Wang, Bachelor · the First Hospital of Hebei Medical UniversityT

  • Jun Zhang, Master · The First Hospital of Hebei Medical University

  • Xiangwei Ren, Master · The First Hospital of Hebei Medical University

  • Qianfeng Liu, Bachelor · The First Hospital of Hebei Medical University

  • Yongbin Di, Master · The First Hospital of Hebei Medical University

  • Boyu Liu, Bachelor · The First Hospital of Hebei Medical University

  • Fan Zhang, Bachelor · The First Hospital of Hebei Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-12-31
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03137979 on ClinicalTrials.gov